glp-1 drug news Medications for Weight Loss: Semaglutide vs Tirzepatide vs Retat – Revolution Health & Wellness GLP-1 drugs may extend life,

GSW, vs

Author contributions S.M: data curation, formal analysis, investigation, methodology, validation, visualization, writingoriginal draft, and funding acquisition

The 2.5 mg dose is better called the low-dose starter, because it is the labeled start and now has short direct non-diabetic data behind it. Microdosing has been used for tolerability testing, metabolic-marker support, step-down protocols, and maintenance, not for proven long-term obesity outcomes

Since high triglycerides are a risk factor for heart disease, and their levels are used in the calculation of LDL (bad) cholesterol, a non-fasting test can provide a falsely alarming picture of your cardiovascular health

Robert-Hazotte, A